Delivery Order SPE2DB22D2006-SPE2DB24FV7ZJ
Award Date
2/6/24
Potential Completion Date
2/7/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,189.30, is a firm fixed-price delivery order for the provision of 4564931397 GRALISE ER 300 MG TABLET 90S. The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract, with a ceiling value of $2,359.80, is for the delivery of the pharmaceutical product Gralise ER 600 mg tablets. The contract is a firm fixed-price Delivery Order with a completion date of February 27, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,213.96 contract is for the supply of GRALISE ER 600 MG TABLET 90S, a prescription medication, with a completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Gralise ER 300 mg tablets. The $3,912.20 firm-fixed-price contract has a completion date of February 16, 2023 and was awarded on February 15, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,824.79, covers the delivery of Gralise ER 600 mg tablets over the period from December 6, 2024, to December 9, 2024. The contract is a firm-fixed-price arrangement, and there is no set-aside designation indicated. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of Gralise ER 600 mg tablets, a prescription medication, and has a ceiling value of $34,639.51. The contract is a firm fixed price delivery order with a performance period through March 13, 2024. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,054.14, is for the procurement of the pharmaceutical product GRALISE ER 600 MG TABLET 90S. The contract has an ultimate completion date of March 6, 2025. This contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the drug GRALISE ER 600 MG TABLET 90S to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,140.50, has an ultimate completion date of September 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,036.96 delivery order contract is for the supply of GRALISE ER 300 MG TABLET 90S, a prescription medication. The contract is a firm fixed price arrangement with a completion date of November 24, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gralise ER 300 mg tablets, a medication used for the treatment of neuropathic pain. The contract has a ceiling value of $37,507.84 and a completion date of December 13, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...